Semler Scientific (NASDAQ:SMLR) Shares Gap Up – What’s Next?

Shares of Semler Scientific, Inc. (NASDAQ:SMLRGet Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $63.40, but opened at $69.36. Semler Scientific shares last traded at $62.44, with a volume of 344,304 shares changing hands.

Semler Scientific Trading Down 4.6 %

The firm has a market capitalization of $501.55 million, a price-to-earnings ratio of 30.93 and a beta of 1.18. The company has a 50-day moving average of $38.24 and a 200-day moving average of $32.86.

Semler Scientific (NASDAQ:SMLRGet Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The company had revenue of $13.51 million for the quarter.

Institutional Trading of Semler Scientific

Several hedge funds have recently made changes to their positions in the stock. Sanctuary Advisors LLC bought a new position in Semler Scientific during the 3rd quarter worth $104,000. Geode Capital Management LLC boosted its holdings in shares of Semler Scientific by 10.5% during the third quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock valued at $3,202,000 after acquiring an additional 12,964 shares during the period. Jane Street Group LLC grew its position in shares of Semler Scientific by 72.3% during the third quarter. Jane Street Group LLC now owns 16,982 shares of the company’s stock worth $400,000 after acquiring an additional 7,126 shares during the last quarter. State Street Corp increased its holdings in shares of Semler Scientific by 0.6% in the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after acquiring an additional 725 shares during the period. Finally, Verition Fund Management LLC bought a new stake in Semler Scientific in the 3rd quarter valued at about $251,000. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Company Profile

(Get Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.

Recommended Stories

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.